Abbott Gets FDA Approval for TAVI System to Treat Aortic Stenosis
The FDA approved Abbott’s new transcatheter aortic valve implantation (TAVI) system, Navitor, to treat people with severe aortic stenosis.
The FDA approved Abbott’s new transcatheter aortic valve implantation (TAVI) system, Navitor, to treat people with severe aortic stenosis.
The U.S. FDA has categorized a recall of Abbot pacemakers caused by a manufacturing process that allowed moisture into the devices as a Class I event; some devices containing the fault could still be in use, reports MedTech Dive.
The FDA approved Abbott’s new transcatheter aortic valve implantation (TAVI) system, Navitor, to treat people with severe aortic stenosis.